On August 27, 2026, two insiders at Abbott Laboratories (ABT) divested a significant portion of their holdings, with transactions totaling approximately $46.20 million. Robert B. Ford, Chairman and CEO, was involved in multiple sales, offloading a total of 398,832 shares across two transactions. The sales occurred at prices of $115.57 and $116.19 per share, realizing approximately $25.26 million and $20.95 million, respectively.
These sales follow earlier activity on August 11, 2026, when another insider, Louis H. Morrone, sold 5,850 shares valued at roughly $642,505. While insider selling can be attributed to various personal financial strategies such as diversification or tax planning, significant and clustered divestitures by multiple executives can sometimes attract investor scrutiny.